Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for GUGCAAA
Z-value: 0.84
Motif logo
miRNA associated with seed GUGCAAA
| Name | miRBASE accession |
|---|---|
|
hsa-miR-19a-3p
|
MIMAT0000073 |
|
hsa-miR-19b-3p
|
MIMAT0000074 |
Activity profile of GUGCAAA motif
Sorted Z-values of GUGCAAA motif
Network of associatons between targets according to the STRING database.
First level regulatory network of GUGCAAA
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.7 | 14.1 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 4.2 | 12.7 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 4.1 | 16.3 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 2.7 | 19.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 2.6 | 7.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 2.5 | 17.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 2.3 | 9.2 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 2.2 | 9.0 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 2.2 | 6.7 | GO:1903722 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) regulation of centriole elongation(GO:1903722) |
| 2.2 | 9.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 2.2 | 8.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 2.2 | 6.5 | GO:1902960 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 2.2 | 6.5 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 2.1 | 6.4 | GO:0070650 | endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 2.0 | 4.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 1.9 | 5.7 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) negative regulation of membrane invagination(GO:1905154) |
| 1.8 | 17.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 1.7 | 5.2 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 1.7 | 5.2 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 1.7 | 8.6 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 1.6 | 4.7 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 1.5 | 10.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 1.5 | 10.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 1.3 | 5.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 1.2 | 3.7 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 1.2 | 2.5 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 1.2 | 7.1 | GO:0097338 | response to clozapine(GO:0097338) |
| 1.1 | 3.4 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 1.1 | 6.7 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
| 1.1 | 3.3 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.1 | 3.2 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 1.1 | 8.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 1.1 | 6.4 | GO:0048840 | otolith development(GO:0048840) |
| 1.0 | 3.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 1.0 | 2.9 | GO:0051946 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 1.0 | 2.9 | GO:0021896 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 1.0 | 5.7 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.9 | 5.6 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.9 | 12.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.9 | 5.5 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.9 | 5.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.8 | 1.6 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.8 | 3.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 0.8 | 2.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.8 | 8.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.8 | 3.9 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
| 0.7 | 2.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.7 | 2.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.7 | 7.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.7 | 2.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.7 | 4.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.7 | 2.8 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
| 0.7 | 4.9 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
| 0.7 | 2.0 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.7 | 6.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.6 | 8.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.6 | 6.4 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
| 0.6 | 1.9 | GO:1903279 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) regulation of calcium:sodium antiporter activity(GO:1903279) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.6 | 1.8 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.6 | 2.4 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.6 | 6.6 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.6 | 4.7 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.6 | 1.7 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.6 | 1.1 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.5 | 7.8 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.5 | 3.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.5 | 5.8 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.5 | 5.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.5 | 0.9 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.5 | 2.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.5 | 9.5 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.4 | 1.8 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.4 | 2.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.4 | 1.3 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.4 | 28.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.4 | 6.5 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.4 | 3.2 | GO:0009597 | detection of virus(GO:0009597) |
| 0.4 | 1.2 | GO:0038156 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.4 | 0.8 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
| 0.4 | 6.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.4 | 3.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.4 | 1.6 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.4 | 2.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.4 | 4.6 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.4 | 13.8 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.4 | 1.8 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.4 | 2.5 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.3 | 3.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 | 4.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.3 | 1.0 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.3 | 1.7 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.3 | 3.7 | GO:2000795 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.3 | 2.3 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
| 0.3 | 1.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.3 | 1.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.3 | 5.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.3 | 2.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.3 | 8.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.3 | 1.2 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.3 | 2.4 | GO:0042256 | mature ribosome assembly(GO:0042256) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.3 | 1.8 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.3 | 5.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.3 | 2.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.3 | 3.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.3 | 1.8 | GO:1903895 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of IRE1-mediated unfolded protein response(GO:1903895) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.3 | 6.4 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.3 | 1.4 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.3 | 1.1 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.3 | 2.0 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.3 | 3.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.3 | 7.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
| 0.3 | 24.4 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.3 | 2.4 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.3 | 0.8 | GO:1902594 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 0.3 | 2.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.3 | 3.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.3 | 5.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.3 | 7.2 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.3 | 6.3 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.2 | 4.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.2 | 10.5 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.2 | 3.0 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.2 | 1.6 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.2 | 3.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.2 | 3.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.2 | 2.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.2 | 2.0 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.2 | 2.4 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.2 | 0.9 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.2 | 5.1 | GO:0042026 | protein refolding(GO:0042026) |
| 0.2 | 2.1 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 0.2 | 1.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.2 | 3.5 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.2 | 0.6 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.2 | 1.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.2 | 2.7 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.2 | 1.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 | 2.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.2 | 0.7 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.2 | 3.6 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
| 0.2 | 1.9 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.2 | 2.4 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 | 2.3 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.2 | 8.8 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.2 | 1.0 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.2 | 0.3 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.2 | 2.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.2 | 7.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
| 0.2 | 2.3 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 | 0.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 | 0.3 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.2 | 4.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.1 | 0.4 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.1 | 2.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 | 2.8 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.1 | 1.1 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 | 5.4 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.1 | 0.6 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.1 | 13.3 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
| 0.1 | 0.4 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.1 | 1.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 | 0.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 | 3.6 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.1 | 0.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.1 | 1.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 4.4 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 | 1.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 1.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 5.5 | GO:0030042 | actin filament depolymerization(GO:0030042) |
| 0.1 | 1.5 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 2.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 2.9 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
| 0.1 | 3.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 | 1.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 | 3.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.1 | 14.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 | 1.6 | GO:0090382 | phagosome maturation(GO:0090382) |
| 0.1 | 2.7 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 | 4.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 | 1.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 5.2 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
| 0.1 | 1.2 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.1 | 1.0 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.1 | 3.8 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.1 | 0.4 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 | 2.8 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.1 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.1 | 0.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.1 | 2.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.3 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.1 | 2.3 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.1 | 11.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 | 1.8 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 | 8.0 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
| 0.1 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 1.0 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.1 | 2.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.1 | 1.3 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.0 | 0.1 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.0 | 1.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
| 0.0 | 0.4 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
| 0.0 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.0 | 0.3 | GO:2001184 | positive regulation of cytokine secretion involved in immune response(GO:0002741) myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.0 | 1.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 | 2.5 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.0 | 1.8 | GO:0016577 | histone demethylation(GO:0016577) |
| 0.0 | 3.0 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.0 | 1.2 | GO:1990090 | cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.0 | 3.9 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.0 | 2.7 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.0 | 3.5 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 | 6.5 | GO:0051168 | nuclear export(GO:0051168) |
| 0.0 | 1.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.0 | 0.9 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 | 3.1 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.0 | 0.7 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.0 | 2.3 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 | 0.4 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.0 | 0.7 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.0 | 0.1 | GO:0048627 | myoblast development(GO:0048627) |
| 0.0 | 2.0 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 | 6.1 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 0.0 | 2.1 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 | 0.2 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.0 | 2.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 | 0.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.0 | 0.1 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
| 0.0 | 0.8 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.0 | 1.0 | GO:0021510 | spinal cord development(GO:0021510) |
| 0.0 | 2.8 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.0 | 0.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 | 6.2 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
| 0.0 | 1.0 | GO:0050679 | positive regulation of epithelial cell proliferation(GO:0050679) |
| 0.0 | 0.5 | GO:0031100 | organ regeneration(GO:0031100) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.8 | 14.1 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 2.6 | 10.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 2.3 | 11.5 | GO:0044308 | axonal spine(GO:0044308) |
| 2.2 | 11.0 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 2.0 | 6.0 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 1.9 | 5.7 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 1.9 | 24.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 1.4 | 12.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 1.3 | 6.5 | GO:0043291 | RAVE complex(GO:0043291) |
| 1.3 | 9.0 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 1.2 | 3.7 | GO:0099569 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
| 1.1 | 5.7 | GO:0033503 | HULC complex(GO:0033503) |
| 0.9 | 3.6 | GO:0071942 | XPC complex(GO:0071942) |
| 0.9 | 16.3 | GO:0005922 | connexon complex(GO:0005922) |
| 0.9 | 8.7 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.8 | 6.6 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.8 | 2.4 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.7 | 10.3 | GO:0090543 | Flemming body(GO:0090543) |
| 0.7 | 2.9 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.6 | 1.3 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.5 | 3.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.5 | 17.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.5 | 17.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.5 | 7.1 | GO:0097433 | dense body(GO:0097433) |
| 0.4 | 1.3 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.4 | 1.3 | GO:0000805 | X chromosome(GO:0000805) |
| 0.4 | 3.5 | GO:0030891 | VCB complex(GO:0030891) |
| 0.4 | 7.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.4 | 7.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.4 | 18.3 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.4 | 4.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.4 | 4.6 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.3 | 4.0 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.3 | 3.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.3 | 4.0 | GO:0005921 | gap junction(GO:0005921) |
| 0.3 | 6.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.3 | 6.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.3 | 3.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.3 | 0.8 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
| 0.3 | 1.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.3 | 6.4 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.3 | 7.4 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.3 | 2.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.2 | 2.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.2 | 1.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.2 | 1.2 | GO:0016589 | NURF complex(GO:0016589) |
| 0.2 | 21.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.2 | 1.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.2 | 2.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.2 | 14.4 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.2 | 2.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 4.8 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.2 | 3.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.2 | 3.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.2 | 2.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.2 | 7.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.2 | 0.9 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.2 | 8.2 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 3.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 0.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.1 | 5.5 | GO:0032420 | stereocilium(GO:0032420) |
| 0.1 | 21.2 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 1.6 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 7.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 8.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.1 | 0.5 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 6.5 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 15.7 | GO:0005875 | microtubule associated complex(GO:0005875) |
| 0.1 | 6.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 2.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 2.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 3.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 31.4 | GO:0005819 | spindle(GO:0005819) |
| 0.1 | 3.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 0.9 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.1 | 13.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.1 | 11.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 2.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.1 | 1.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.1 | 1.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 3.8 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 1.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.1 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 2.4 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.1 | 2.9 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.1 | 3.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 0.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 2.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 5.7 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
| 0.1 | 3.4 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.1 | 4.0 | GO:0036126 | sperm flagellum(GO:0036126) |
| 0.1 | 4.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 5.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.1 | 9.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.1 | 4.6 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) GAIT complex(GO:0097452) |
| 0.1 | 19.7 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.1 | 0.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.1 | 3.8 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
| 0.1 | 1.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 0.7 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.0 | 3.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.0 | 1.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 7.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.0 | 6.4 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.0 | 1.2 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.0 | 0.8 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 2.3 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 4.7 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 4.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.4 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 8.1 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.0 | 13.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.0 | 0.6 | GO:0005811 | lipid particle(GO:0005811) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.7 | 18.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 2.8 | 14.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 2.7 | 16.3 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 2.6 | 15.6 | GO:0034046 | poly(G) binding(GO:0034046) |
| 2.1 | 6.3 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 2.0 | 7.8 | GO:0004513 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 1.6 | 7.9 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 1.5 | 6.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 1.5 | 6.0 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 1.3 | 13.4 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
| 1.1 | 8.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 1.0 | 2.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.9 | 20.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.9 | 6.5 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.9 | 6.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.9 | 3.5 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 0.9 | 9.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.9 | 3.5 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 0.9 | 2.6 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.9 | 7.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.8 | 4.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.8 | 2.5 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.8 | 5.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.8 | 2.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.8 | 9.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.7 | 7.2 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.7 | 6.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.7 | 4.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.7 | 2.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.6 | 5.6 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.6 | 2.4 | GO:0043273 | CTPase activity(GO:0043273) |
| 0.6 | 7.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.6 | 3.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.5 | 5.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.5 | 13.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.5 | 1.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.5 | 9.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.5 | 2.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.5 | 1.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.5 | 3.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.4 | 13.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.4 | 2.6 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
| 0.4 | 12.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.4 | 1.2 | GO:0004914 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
| 0.4 | 1.6 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.4 | 34.0 | GO:0019003 | GDP binding(GO:0019003) |
| 0.4 | 1.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.4 | 1.1 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.3 | 1.0 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.3 | 7.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.3 | 3.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.3 | 3.0 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.3 | 3.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.3 | 1.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.3 | 4.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.3 | 8.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.3 | 3.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.3 | 3.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.3 | 17.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.3 | 4.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.3 | 10.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.3 | 1.1 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 0.3 | 16.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.3 | 1.8 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.2 | 4.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.2 | 4.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.2 | 2.8 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.2 | 5.0 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.2 | 2.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) steroid hormone binding(GO:1990239) |
| 0.2 | 6.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.2 | 4.0 | GO:0005522 | profilin binding(GO:0005522) |
| 0.2 | 0.9 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.2 | 10.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.2 | 1.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.2 | 12.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.2 | 15.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.2 | 8.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.2 | 5.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.2 | 2.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.2 | 6.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.2 | 5.7 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.2 | 2.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.2 | 1.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.2 | 6.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.2 | 8.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.2 | 8.2 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.2 | 7.6 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
| 0.2 | 2.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.2 | 3.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.2 | 0.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.2 | 1.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.2 | 0.9 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.1 | 2.8 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 2.7 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 7.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 2.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.1 | 2.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.1 | 1.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) lipid phosphatase activity(GO:0042577) |
| 0.1 | 0.9 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 1.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.1 | 0.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.1 | 2.6 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 1.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 2.8 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 2.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 0.3 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
| 0.1 | 7.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 1.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.1 | 1.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 5.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 1.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 3.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 0.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 29.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 2.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.1 | 2.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 0.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.1 | 1.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.1 | 1.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.1 | 2.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 1.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 8.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 1.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 1.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 10.4 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 2.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.1 | 1.1 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
| 0.1 | 1.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.0 | 3.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.7 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.0 | 0.2 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.0 | 11.4 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.0 | 1.2 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 1.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 0.5 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
| 0.0 | 1.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.0 | 0.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.0 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 7.8 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.0 | 2.3 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.0 | 9.8 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.0 | 1.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 6.5 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 1.8 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 15.3 | GO:0003779 | actin binding(GO:0003779) |
| 0.0 | 1.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 2.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.0 | 1.6 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
| 0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.0 | 0.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.0 | 1.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 13.0 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.0 | 1.0 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
| 0.0 | 1.8 | GO:0020037 | heme binding(GO:0020037) |
| 0.0 | 2.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.4 | GO:0017016 | Ras GTPase binding(GO:0017016) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 10.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.4 | 20.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.3 | 4.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.3 | 13.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.3 | 16.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.3 | 17.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.3 | 14.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.3 | 13.0 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.3 | 10.7 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.3 | 16.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.2 | 8.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.2 | 6.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.2 | 11.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 8.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.2 | 1.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.2 | 4.7 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.2 | 9.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.2 | 10.7 | PID BMP PATHWAY | BMP receptor signaling |
| 0.2 | 6.3 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.2 | 6.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.2 | 3.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.1 | 6.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 8.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 3.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 6.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.1 | 8.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 2.3 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 3.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 7.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 7.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 2.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.1 | 2.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.1 | 1.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 1.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 2.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 3.5 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.1 | 1.9 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 2.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 1.1 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 2.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 3.1 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 4.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.0 | 1.2 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 1.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 1.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 4.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.0 | 0.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 25.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.8 | 16.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.7 | 10.2 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.7 | 16.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.6 | 1.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.5 | 13.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.4 | 0.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.4 | 5.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.4 | 12.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.4 | 5.5 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.3 | 5.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.3 | 11.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.3 | 2.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.3 | 10.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.3 | 5.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.2 | 6.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.2 | 3.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.2 | 5.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.2 | 6.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.2 | 2.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.2 | 4.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.2 | 3.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.2 | 8.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.2 | 4.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.2 | 4.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 5.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 4.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 2.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 6.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 2.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.1 | 6.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.1 | 6.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 19.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 3.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.1 | 1.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 3.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 7.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 2.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.1 | 13.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 2.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 6.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 3.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 1.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 6.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.1 | 1.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.1 | 0.1 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
| 0.1 | 1.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 2.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.1 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 2.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 0.3 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
| 0.1 | 7.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.1 | 5.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 2.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.0 | 0.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.0 | 0.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.0 | 1.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 1.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 2.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 1.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.0 | 0.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.0 | 0.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.0 | 2.3 | REACTOME S PHASE | Genes involved in S Phase |
| 0.0 | 1.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 0.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 3.8 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 0.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.0 | 1.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 4.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.0 | 1.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |